RxDoctor Payments Data

Olga Colac

Family · Atlanta, GANPI 1245553015

Payments from drug & device makers

$4,373in general payments, 2019–2025

Across 267 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • IBSA Pharma Inc.$705
  • AbbVie$659
  • Abbott$372
  • Scilex Pharmaceuticals Inc.$306
  • Collegium Pharmaceutical, Inc.$232
  • plus $876 from 21 others

What the payments were for

  • Food & beverage$4,33899%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,373 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide124$282,791
ZtlidoLidocaine75$59,567
MovantikNaloxegol Oxalate70$28,816
UbrelvyUbrogepant16$27,222
BelbucaBuprenorphine Hcl31$21,209
Lidocaine148$13,398
Gabapentin567$7,295
LicartDiclofenac Epolamine16$6,898
Naloxone Hcl91$6,335
Pregabalin285$4,876
Buprenorphine16$4,128
Diclofenac Sodium128$3,139
Tizanidine Hcl282$3,085
Baclofen333$2,575
Tramadol Hcl ErTramadol Hcl32$2,146

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,223$282,791124 claims
Scilex Pharmaceuticals Inc.Ztlido$306$59,56775 claims
Redhill Biopharma Inc.Movantik$17$28,81670 claims
AbbVieUbrelvy$659$27,22216 claims
Collegium Pharmaceutical, Inc.Belbuca$232$21,20931 claims
IBSA Pharma Inc.Licart$705$6,89816 claims
Hikma Pharmaceuticals USABuprenorphine$131$4,12816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →